Literature DB >> 20575800

The FAS Screen: a rapid screening tool for fetal alcohol syndrome.

L Burd1, C Cox, B Poitra, T Wentz, M Ebertowski, J T Martsolf, J Kerbeshian, M G Klug.   

Abstract

Fetal alcohol syndrome (FAS) is an important cause of mental retardation and developmental disabilities. A population based screening tool would allow for early diagnosis and entry into intervention programs. The aim of the study was to develop a brief screening tool for use in population-based settings to improve the identification of children with FAS. The FAS Screen was developed and tested in six sites. These were sites that served children and all were located in North Dakota. Screening was completed on 1013 children, 65 were found to have a positive screening score and were referred for further investigation. Forty were seen for evaluation by a medical geneticist and six were diagnosed with FAS. The estimated values for the screening tool were: specificity 94.1%, sensitivity 100%, positive predictive value 9.1% and negative predictive value 100%. The cost of screening was $13.00 per child and the cost per case identified was $4,100. The FAS Screen is a brief screening test with acceptable performance characteristics and is cost effective.

Entities:  

Year:  1999        PMID: 20575800     DOI: 10.1080/13556219971542

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  5 in total

1.  Estimating the community prevalence, child traits, and maternal risk factors of fetal alcohol spectrum disorders (FASD) from a random sample of school children.

Authors:  Philip A May; Julie M Hasken; Stephen R Hooper; Dixie M Hedrick; Julia Jackson-Newsom; Chalise E Mullis; Elizabeth Dobyns; Wendy O Kalberg; David Buckley; Luther K Robinson; Omar Abdul-Rahman; Margaret P Adam; Melanie A Manning; Tamison Jewett; H Eugene Hoyme
Journal:  Drug Alcohol Depend       Date:  2021-08-02       Impact factor: 4.852

2.  Prevalence and characteristics of fetal alcohol syndrome and partial fetal alcohol syndrome in a Rocky Mountain Region City.

Authors:  Philip A May; Carol Keaster; Rosemary Bozeman; Joelene Goodover; Jason Blankenship; Wendy O Kalberg; David Buckley; Marita Brooks; Julie Hasken; J Phillip Gossage; Luther K Robinson; Melanie Manning; H Eugene Hoyme
Journal:  Drug Alcohol Depend       Date:  2015-08-14       Impact factor: 4.492

3.  Prevalence of fetal alcohol spectrum disorder among special subpopulations: a systematic review and meta-analysis.

Authors:  Svetlana Popova; Shannon Lange; Kevin Shield; Larry Burd; Jürgen Rehm
Journal:  Addiction       Date:  2019-04-29       Impact factor: 6.526

4.  Fetal Alcohol Spectrum Disorders in a Midwestern City: Child Characteristics, Maternal Risk Traits, and Prevalence.

Authors:  Philip A May; Julie M Hasken; Amy Baete; Jaymi Russo; Amy J Elliott; Wendy O Kalberg; David Buckley; Marita Brooks; Marian A Ortega; Dixie M Hedrick; Barbara G Tabachnick; Omar Abdul-Rahman; Margaret P Adam; Tamison Jewett; Luther K Robinson; Melanie A Manning; H Eugene Hoyme
Journal:  Alcohol Clin Exp Res       Date:  2020-04-15       Impact factor: 3.455

5.  Fetal Alcohol Spectrum Disorders in a Rocky Mountain Region City: Child Characteristics, Maternal Risk Traits, and Prevalence.

Authors:  Philip A May; Julie M Hasken; Rosemary Bozeman; Jo-Viviane Jones; Mary Kay Burns; Joelene Goodover; Wendy O Kalberg; David Buckley; Marita Brooks; Marian A Ortega; Amy J Elliott; Dixie M Hedrick; Barbara G Tabachnick; Omar Abdul-Rahman; Margaret P Adam; Tamison Jewett; Luther K Robinson; Melanie A Manning; H Eugene Hoyme
Journal:  Alcohol Clin Exp Res       Date:  2020-04-15       Impact factor: 3.455

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.